Case Report
Published: 19 July, 2018 | Volume 2 - Issue 1 | Pages: 020-022
Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idiopathic arthritis who developed peripheral neuropathy few months after TNF inhibitor withdrawal with clinical worsening of the neurological sequelae while undergoing treatment with abatacept.
Read Full Article HTML DOI: 10.29328/journal.apps.1001008 Cite this Article Read Full Article PDF
Juvenile idiopathic arthritis; TNF- inhibitor; Abatacept; Demyelination neuropathy
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."